×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [5]
中国医学科学院 北京... [3]
西安交通大学 [2]
海洋研究所 [1]
山东大学 [1]
内容类型
期刊论文 [12]
发表日期
2019 [3]
2018 [2]
2017 [1]
2016 [3]
2015 [2]
2014 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
内容类型:期刊论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:
Si Xiaoyan
;
Zhang Li
;
Wang Hanping
;
Zhang Xiaotong
;
Wang Mengzhao
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/11/19
non-small cell lung cancer
multi-target tyrosine kinase inhibitor
Adverse event
anlotinib
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303
期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/12/11
Adverse event
anlotinib
multi-target tyrosine kinase inhibitor
non-small cell lung cancer
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303
期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Adverse event
anlotinib
multi-target tyrosine kinase inhibitor
non-small cell lung cancer
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models
期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 2, 页码: 243-250
作者:
Jiang, Xi-fei
;
Dai, Yang
;
Peng, Xia
;
Shen, Yan-yan
;
Su, Yi
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2019/01/08
human cancer
anticancer drug
SOMCL-085
receptor tyrosine kinase
FGFR
xenograft nude mouse model
somcl085anovelmultitargetedfgfrinhibitordisplayspotentanticanceractivityinfgfraddictedhumancancermodels
期刊论文
actapharmacologicasinica, 2018, 卷号: 39, 期号: 2, 页码: 243
作者:
Jiang Xifei
;
Dai Yang
;
Peng Xia
;
Shen Yanyan
;
Su Yi
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/07/01
human cancer
anticancer drug
SOMCL-085
receptor tyrosine kinase
FGFR
xenograft nude mouse model
Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 126, 页码: 122-132
作者:
Liu, Yang
;
Peng, Xia
;
Guan, Xiaocong
;
Lu, Dong
;
Xi, Yong
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2019/01/08
FGFR
KDR
Inhibitor
Anticancer
Ponatinib
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9
作者:
Sun, Yongkun
;
Niu, Wei
;
Du, Feng
;
Du, Chunxia
;
Li, Shuting
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/01/08
Anlotinib
Anti-angiogenesis
Phase I study
Advanced refractory solid tumors
Pharmacokinetics
Safety
Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 卷号: 24, 期号: [db:dc_citation_issue], 页码: 750-758
作者:
Shan, Yuanyuan
;
Wang, Chen
;
Zhang, Lin
;
Wang, Jinfeng
;
Wang, Maoyi
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/02
Diarylurea
Inhibitor
Structural diversity
Receptor tyrosine kinase
Multi-target
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
期刊论文
2016, 卷号: 9, 期号: 1, 页码: 105
作者:
Sun, Yongkun
;
Niu, Wei
;
Du, Feng
;
Du, Chunxia
;
Li, Shuting
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Anlotinib
Anti-angiogenesis
Phase I study
Advanced refractory solid tumors
Pharmacokinetics
Safety
Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects
期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 卷号: 16, 期号: 6, 页码: 13548-13560
作者:
Wang, Shuaiyu
;
Wang, Li-Jun
;
Jiang, Bo
;
Wu, Ning
;
Li, Xiangqian
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2015/12/07
©版权所有 ©2017 CSpace - Powered by
CSpace